Tingting Yue
*** ******* ***, ****, ** *****
*****.***@*****.*** (Cell) 919-***-****
Objective
A motivated and detail-orientated scientist with 4 years experience of
analytics in clinical research, plus a multidisciplinary training and
experience in science, engineering, bioinformatics, epidemiology and
statistics, is seeking a full-time analysis and research position in
life-science industries in North Carolina.
SUMMAry OF qualifications
Work Competence
Four years experience in bioinformatics and statistical analysis for
Phase I & II biomarker study. Expertise in study design of clinical
screening assays, bioinformatics data-mining of "omics" study, and
statistical data analysis for high-throughput study. In-depth training
in next-gen sequencing analysis. Certified SAS programmer. Proficiency
in multiple bioinformatics and statistical tools.
Communication Skills
Demonstrated success in presenting and documenting research results for
scientific publications in "omics" journal and epidemiology meeting.
Successful experience in communicating bioinformatics and statistical
data processing to non-statisticians. Excellent interpersonal skills
developed from leading research and collaborating with researchers in
industry and academics. Experience in student training and knowledge
transfer.
Additional expertise and potential
Four years hands-on experience in conducting data collection of clinical
research plus 1 year experience in regenerative medicine research. A
professional sense of data analysis developed from the multidisciplinary
research experience. Quick learner of new data analysis methods and new
domain knowledge.
Education
10/2010 Ph.D. Cell and Molecular Biology, Michigan State University,
East Lansing, United States.
12/2005 Master of Research (M.Res.) Regenerative Medicine, Center of
Regenerative Medicine, University of Bath, Bath, United Kingdom.
06/2003 B.S. Biotechnology, Huazhong University of Science and
Technology, Wuhan, China
Certification SAS base programming certificate for SAS 9
Experience
05/2006 - Present, Van Andel Research Institute, Grand Rapids, MI, Graduate
research assistant. Lead scientist of the Phase I & II biomarker study in
Laboratory of Cancer Immunodiagnostics.
Bioinformatics analysis to develop biomarker panel enhancing cancer
diagnosis
-Developed a patentable biomarker panel to improve patient
stratification and reduce the healthcare cost for pancreatic cancer
diagnosis.
-Developed and optimized a glycoproteomic solution for diagnostic
biomarker development.
-Developed a standard strategy which is continuously used by the lab to
select biomarker panel.
-Characterized the biological insights of the molecular epidemiology of
the biomarkers.
-Designed and conducted the biomarker screening of 400 candidate markers
from 5 independent sample sets including 450 clinical samples.
Database development for Consortium for Functional Glycomics (CFG)
glycan microarray
-Implemented the motif-segregation algorithm to convert 17,244 raw
microarray data values into a widely-used public database providing
information of lectin binding specificities.
Multiplex microarray method testing and evaluation for Gentel
Biosciences, Inc.
-Tested and evaluated the method at a high-throughput sample processing
platform.
-Improved the cost-effectiveness of this protocol which has been
commercialized successfully.
Verbal and written presentation of research
-Published more than 5 peer-reviewed articles about high-throughput
clinical study and database development.
-Presented the data analysis at 9 international conferences in different
fields including cancer research, proteomics, clinical research,
glycomics, and epidemiology.
-Assisted technology transfer by documenting invention disclosures for
the patent application of a diagnostic biomarker panel.
-Provided technical report to Gentel Biosciences, Inc. for the
evaluation of the multiplex assay.
-Secured additional funding by documenting successful research results
in a grant application.
-Provided description of published results for press release targeting
non-scientific readers.
-Effectively communicated with collaborators including physicians,
statisticians and biologists.
10/2004-03/2005 Center of Regenerative Medicine, University of Bath, U.K.
Research student
Dept. of Chemical Engineering In vitro simulation of PLGA scaffold
degradation for bioreactor design in bone tissue engineering.
Dept. of Biology and Biochemistry Characterized expression pattern of
gene Id2 in the zebrafish pigmentation model to study the
differentiation of neural crest stem cells.
Teamwork and Leadership
05/2006 -06/2010 Collaborated with Early Diagnosis Research Network
(EDRN) for biomarker development (Collaborators including Evanston
Northwestern Healthcare, U of Pittsburgh, U of Michigan, Fred Hutchinson
Cancer Research Center, Michigan Proteome Consortium).
01/2010-06/2010 Led data collection and bioinformatics analysis of a
double-blinded clinical profiling study collaborating with U of
Pittsburgh and Fred Hutchinson Cancer Research Center.
06/2008-06/2010 Technical training and research mentoring of 2 lab
technicians and 3 undergraduate student interns.
Teaching experience
08/2006-12/2006 Teaching assistant, Dept. of Biochemistry and Molecular
Biology, MSU, Course title: "Introduction to Biochemistry", class size:
96 undergraduate students
SUMMAry OF skills
Analytical and Computer Skills
Statistical: Multivariate analysis, Receiver operating characteristic
(ROC) analysis, Survival analysis, Statistical regression, Bayesian
methods, Power calculation, Categorical analysis, Non parametric
analysis, Analysis of variance (ANOVA), Machine learning, Pattern
recognition, Hypothesis testing, cluster, Multiple comparisons
Bioinformatics: Microarray and mass spectrometry data-mining, Study
design for high-throughput screening, Data mining and data management
for molecular biomarker study, Biomarker panel selection, Genome-wide
association study (GWAS) analysis by GenABEL, Patient stratification for
drug development, CGH expression data analysis
Software/programming: SAS (certified programmer), R, MATLAB, Origin,
Cluster, Perl, Atlas.ti
Research Skills
General: DNA/RNA/protein isolation, Molecular cloning, Gene knockdown,
RT-PCR, Real-time PCR (Q-PCR), PCR, In-situ hybridization, Western Blot,
Immunoprecipitation, Protein purification, Cell culture, Cell-based
assays
Proteomics: Protein microarray assays, Glycoproteomics assays, ELISA
Equipment: Automated liquid handler, High-performance liquid
chromatography (HPLC), Fast protein liquid chromatography (FPLC), Atomic
force microscopy, Microarray printer
Awards
Graduate Student Fellowship (Van Andel Research Institute, 2005-2006)
Student Travel Award (Society of Glycobiology annual meeting, 2008 and
2009)
Student Travel Award (US HUPO annual meeting, 2010)
Scholar-In-Training Award (American Assc. of Cancer Research (AACR)
annual meeting 2010)
Scholar-In-Training Award (AACR Molecular Epidemiology annual meeting,
2010)
Dissertation Completion Fellowship (Michigan State University, 2010)
Publications
1. T. Yue, I.J.Goldstein, M.A.Hollingsworth, K.Kaul, R.E.Brand, B.B.Haab
(2009). The prevalence and nature of glycan alterations on specific
proteins in pancreatic cancer patients revealed using antibody-lectin
sandwich arrays. Mol Cell Proteomics. 8,1697-1707
2. T. Yue, B.B.Haab (2009). Microarrays in glycoproteomics research. Clin
Lab Med. 29, 15-29.
3. A.Porter, T. Yue (co-first author), L.Heeringa, S.Day, E.Suh, B.B.Haab
(2010). A motif-based analysis of glycan array data to determine the
specificties of glycan-binding proteins. Glycobiology. 20(3):369-80
4. B.B.Haab and T. Yue (2010). High-throughput studies of protein
glycoforms using antibody-lectin sandwich assays. Methods Mol.Biol.
(In press)
5. B.B.Haab, A.Porter, T. Yue, L.Li, J. Scheiman, M.A.Anderson, D.Barnes,
C.M.Schmidt, Z.Feng, D.M.Simeone (2010). Glycosylation variants of
mucins and CEACAMs as candidate biomarkers for the diagnosis of
pancreatic cystic neoplasms. Annals of Surgery. 251(5):937-45.
6. T. Yue, R.E.Brand, M.A.Anderson, D.M.Simeone, B.B.Haab. Enhanced
sensitivity of pancreatic cancer detection by measuring the CA19-9
antigen on selected protein carriers. (In preparation for submission
to JNCI or Cancer Res)
7. T. Yue, R.E.Brand, M.Hurley, P.Andrews, B.B. Haab. Identification of
novel CA19-9 carrier revealed the need to fine-tune CA19-9 for
pancreatic cancer detection. (In preparation)
Conference presentations
1. T. Yue, I.J.Goldstein, M.A.Hollingsworth, R.E.Brand, B.B.Haab (2007).
Glycan variation on serum mucins in pancreatic cancer. Annual meeting
of the Society of Glycobiology. (Poster)
2. T. Yue, I.J.Goldstein, M.A.Hollingsworth, R.E.Brand, B.B.Haab (2008).
Glycan alterations on serum mucins in pancreatic cancer. Annual
meeting of American Association of Cancer Research (AACR). (Poster)
3. A.Porter, T. Yue, L.Li, J.Scheiman, M.A. Anderson, D.Barnes,
C.M.Schmidt, Z.Feng, D.M. Simeone, B.B.Haab (2008). Glycosylation
Variants of Mucins and CEACAMs As Candidate Biomarkers for the
Diagnosis of Pancreatic Cystic Neoplasms. American Pancreatic
Association annual meeting. (Oral presentation)
4. T. Yue, I.J.Goldstein, M.A.Hollingsworth, K.Kaul, R.E.Brand, B.B. Haab
(2008). The prevalence and nature of glycan alterations on specific
proteins in pancreatic cancer patients revealed by antibody-glycan
sandwich arrays. Annual meeting of the Society of Glycobiology.
(Poster)
5. T. Yue, I.J.Goldstein, M.A.Hollingsworth, K.Kaul, R.E.Brand, B.B. Haab
(2009). Varation in carrier proteins of the CA19-9 antigen in patients
with benign and malignant pancreatic disease. Annual meeting of AACR.
(Poster)
6. A.Porter, L.Heeringa, T. Yue(co-first author), G.Michailidis, B.B.Haab
(2009). A motif-based analysis of glycan array data to define the
specificities of glycan-binding proteins. Annual meeting of the
Society of Glycobiology. (Poster)
7. T. Yue, L.Li, M.A.Anderson, D.E.Brenne, D.M.Simeone, Z.Feng,
R.E.Brand, B.B.Haab (2010). Candidate Biomarkers for Pancreatic Cancer
Evaluated Using Antibody-Lectin Sandwich Arrays in Multiple Sample
Sets. Annual meeting of US HUPO. (Oral presentation)
8. T. Yue, M.C.Hurley, R.E.Brand, P.C. Andrews, B.B. Haab (2010).
Pancreatic disease-specific carriers of the CA 19-9 antigen identified
by antibody microarrays and mass spectrometry. Annual meeting of AACR.
(Poster)
9. T. Yue, L.Li, M.A.Anderson, D.M.Simeone, Z.Feng, R.E.Brand, B.B.Haab
(2010). Candidate biomarkers for pancreatic cancer evaluated using
antibody-lectin sandwich arrays in multiple serum sample sets. AACR
special meeting, "The Future of Molecular Epidemiology". (Poster)